The concept of a causal role of pro-inflammatory cytokines mediating cachexia in humans has only been addressed very limitedly and only in a few pathological conditions, using targeted therapeutics that deplete specific cytokines such as TNF-α and IL-6. The gene discussed is IL6; the disease is Cachexia.